Neurocrine Bioscience buy JPMorgan Chase & Co.
Start price
23.02.24
/
50%
€124.00
Target price
23.02.25
€136.69
Performance (%)
3.15%
Price
19:32
€127.90
Summary
This prediction is currently active. With a performance of 3.15%, the BUY prediction by JPMorgan_Chase___Co_ for Neurocrine Bioscience is trending in the right direction. This prediction currently runs until 23.02.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | -1.795% | -1.795% |
iShares Core DAX® | -0.205% | 2.528% |
iShares Nasdaq 100 | 1.613% | 4.733% |
iShares Nikkei 225® | -0.740% | 0.396% |
iShares S&P 500 | 0.267% | 2.720% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target lowered by analysts at JPMorgan Chase & Co. from $154.00 to $148.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€128.85
20.03.24
20.03.24
€145.64
20.03.25
20.03.25
-0.74%
19:32
19:32
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€124.83
13.09.24
13.09.24
19.25%
19:32
19:32